Structures by: Shanmugam G.
Total: 19
N-Methyl-2,4-diphenyl-7-tertiary butyl 3-azabicyclo[3.3.1]nonane
C25H33N
Acta Crystallographica Section B (1999) 55, 5 793-798
a=13.6670(10)Å b=16.414(2)Å c=9.4090(10)Å
α=90.00° β=94.540(10)° γ=90.00°
N-Acetyl-2,4-diphenyl-3-azabicyclo[3.3.1]nonane
C22H25NO
Acta Crystallographica Section B (1999) 55, 5 793-798
a=14.6870(10)Å b=12.9310(10)Å c=18.5640(10)Å
α=90.00° β=90.00° γ=90.00°
N-Methyl-2,4-diorthomethyl phenyl-9-hydroxy 3-azabicyclo[3.3.1]nonane
C23H29NO
Acta Crystallographica Section B (1999) 55, 5 793-798
a=7.6380(10)Å b=13.1880(10)Å c=18.865(2)Å
α=90.00° β=97.940(10)° γ=90.00°
Ethyl 3-methyl-1-(2,4-dinitrophenyl)-1H-pyrazole-4-carboxylate
C13H12N4O6
Acta Crystallographica Section E (2003) 59, 11 o1835-o1837
a=7.7531(8)Å b=9.7146(10)Å c=11.4051(12)Å
α=113.649(2)° β=92.989(2)° γ=109.089(2)°
Myricetin
C19H18O8
Acta Crystallographica Section E (2005) 61, 4 o846-o848
a=30.958(7)Å b=7.9544(19)Å c=14.263(6)Å
α=90.00° β=95.53(3)° γ=90.00°
2,2'-piperazin-1,4-diyldimethylene-bis[6-(cyclohexyliminimethyl) -4-methylphenol]
C34H48N4O2
Acta Crystallographica Section C (1998) 54, 3 365-367
a=11.4598(10)Å b=12.5892(11)Å c=11.1347(12)Å
α=90.00° β=97.996(7)° γ=90.00°
5,5'-Dibromo-2,2'-dihydroxy-3,3'-(piperazine-1,4-diyldimethylene) dibenzaldehyde
C20H20Br2N2O4
Acta Crystallographica Section C (1998) 54, 6 780-781
a=8.825(2)Å b=16.518(2)Å c=7.368(2)Å
α=90.00° β=111.39(2)° γ=90.00°
1-[2-(napthylenyl)]-3-(4-chlorophenyl)-2-propen-1-one
C19H13ClO
Acta Crystallographica Section C (1997) 53, 7 917-918
a=5.911(4)Å b=7.474(3)Å c=16.366(3)Å
α=100.55(3)° β=91.90(3)° γ=91.62(4)°
{4,4'-Dimethyl-6,6'-bis(1-morpholiniomethyl)-2,2'-[1,2- ethanediylbis(nitrilomethylidene-N)]diphenolato-O,O'}copper(II) diperchlorate monohydrate
[CuC28H38N4O4],2ClO4,H2O
Acta Crystallographica Section C (1999) 55, 6 894-896
a=8.9654(3)Å b=9.6447(3)Å c=20.0666(5)Å
α=78.4750(10)° β=81.5180(10)° γ=83.7860(10)°
1-[2-(napthalenyl)]-3-(3-nitrophenyl)-2-propen-1-one
C19H13NO3
Acta Crystallographica Section C (1998) 54, 4 541-542
a=10.317(2)Å b=5.864(4)Å c=24.5820(10)Å
α=90.00° β=100.15(2)° γ=90.00°
C19H13NO3
C19H13NO3
Acta Crystallographica Section C (1996) 52, 12 3145-3146
a=6.060(2)Å b=7.185(3)Å c=16.872(6)Å
α=101.44(3)° β=91.93(3)° γ=86.93(4)°
1,4-bis[2'hydroxy-3'-(N-ethylimino)-5'-methylbenzyl]-piperazine
C26H36N4O2
Acta Crystallographica Section C (1998) 54, 5 644-645
a=19.033(2)Å b=13.6610(10)Å c=9.5460(10)Å
α=90.0° β=95.720(10)° γ=90.0°
2-Hydroxy-5-methyl-3-(morpholinomethyl)benzaldehyde
C13H17NO3
Acta Crystallographica Section C (1999) 55, 1 94-97
a=5.31720(10)Å b=15.3099(3)Å c=15.34060(10)Å
α=90.00° β=91.8460(10)° γ=90.00°
4,4'-Dimethyl-6,6'-bis(morpholinomethyl)-2,2'-ethylene dinitrilodimethylidyne)diphenol
C28H38N4O4
Acta Crystallographica Section C (1999) 55, 1 94-97
a=11.1356(5)Å b=9.5825(5)Å c=12.4721(6)Å
α=90.00° β=98.828(2)° γ=90.00°
{4,4'-Dimethyl-6,6'-bis(morpholinomethyl)-2,2'-[1,3- propanediylbis(nitrilomethylidene)]diphenolato-O,N,N',O'}manganese(II) diperchlorate monohydrate
C28H38Cl2MnN4O13
Acta Crystallographica Section C (1999) 55, 8 1218-1220
a=8.91620(10)Å b=9.67640(10)Å c=20.07660(10)Å
α=78.5360(10)° β=81.5200(10)° γ=83.9220(10)°
Intramolecular N-H...π(Phenyl) and Intermolecular C-H...π(Phenyl) Interaction in 5-Amino-8-cyano-2-phenyl-4(4-methoxy-phenyl-7- (piperidine-1-yl)-1,6-Naphthyridine
C27H25N5O,0.5C6H6
Acta Crystallographica Section C (1999) 55, 9 1522-1524
a=9.64770(10)Å b=14.9004(2)Å c=18.0803(3)Å
α=75.9200(10)° β=84.2060(10)° γ=75.5460(10)°
Spiro indolone
C21H15N5O2
Acta Crystallographica Section E (2008) 64, 1 o341-o341
a=10.0370(3)Å b=21.9705(6)Å c=8.2325(2)Å
α=90.00° β=98.7610(10)° γ=90.00°
Isoxazolidine
C26H24BrN3O2
Acta Crystallographica Section E (2008) 64, 1 o342-o342
a=27.7493(6)Å b=7.4254(2)Å c=24.5230(5)Å
α=90.00° β=114.5160(10)° γ=90.00°
Bis(glycine) calcium(II) diiodide trihydrate
C4H16CaN2O72,2(I)
Acta Crystallographica Section E (2007) 63, 12 m2897-m2898
a=13.065(8)Å b=9.861(4)Å c=22.731(9)Å
α=90.00° β=90.00° γ=90.00°